Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ipsen
AddedFeb 17, 2024
UpdatedJun 28, 2026
Ipsen

Ipsen

Public

Ipsen, a global French pharmaceutical firm, specializes in oncology, rare diseases, and neuroscience.

HQ
Boulogne-Billancourt, Hauts-de-Seine, FR
Founded
1929
Overview
Compare
Fundraising
Employees
Website

Founded in 1929 by Henri Beaufour, Ipsen is a global French pharmaceutical company headquartered in Boulogne-Billancourt, France. The company's core mission is to improve patients' lives through innovative medicines in oncology, rare diseases, and neuroscience. Ipsen develops and markets a range of specialized medicines and serves customers worldwide, focusing on providing advanced therapeutic solutions.

Notable figures associated with Ipsen include Marc de Garidel, the Non-executive Chairman, and David Loew, the Chief Executive Officer. Ipsen is publicly traded on Euronext Paris under the ticker IPN and is a component of the CAC Mid 60. In 2021, the company reported a revenue of €2.87 billion and an operating income of €1.01 billion. Ipsen's impactful contributions to the pharmaceutical industry are reflected in its robust financial performance and its commitment to addressing complex medical needs globally.

Ipsen - Similar Companies

Sanofi logo

Sanofi

sanofi.com

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

UCB logo

UCB

ucb.com

Janssen logo

Janssen

janssen.com

Astellas Pharma logo

Astellas Pharma

Ferring logo

Ferring

ferring.com

Eisai Co. logo

Eisai Co.

Novartis Pharma logo

Novartis Pharma

Eli Lilly and Company logo

Eli Lilly and Company

lilly.com

AstraZeneca logo

AstraZeneca

astrazeneca.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Incyte logo

Incyte

incyte.com

Seppic logo

Seppic

AbbVie logo

AbbVie

abbvie.com

Ipsen - Quick Facts

Who are Ipsen's competitors?

Companies similar to Ipsen include Sanofi, Bristol Myers Squibb, Ionis Pharmaceuticals and UCB.

When was Ipsen founded?

Ipsen was founded in 1929.

Where is Ipsen's headquarters located?

Ipsen's headquarters is located in Boulogne-Billancourt, Hauts-de-Seine, FR.

When was Ipsen's last funding round?

Ipsen's most recent funding round was for $22M (USD) in November 2017.

How much has Ipsen raised to-date?

As of Nov 20, 2017, Ipsen has raised a total of $22M (USD).

How many employees does Ipsen have?

Ipsen has 5,700 employees as of Feb 12, 2024.

Ipsen - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Pharmaceuticals
Tags
  • Pharma
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 7010Activities of head offices
Show 18 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 550000Management of Companies and Enterprises
  • 551000Management of Companies and Enterprises
  • 551100Management of Companies and Enterprises
  • 551110Management of Companies and Enterprises
  • 551114Corporate, Subsidiary, and Regional Managing Offices
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research